RILA’s Kathleen McGuigan to retire at end of 2025
During her tenure, McGuigan became a central figure in the organization’s legal and regulatory efforts.
During her tenure, McGuigan became a central figure in the organization’s legal and regulatory efforts.
Phenylephrine Hydrochloride Injection, USP is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
In a securities filing, Kohl’s disclosed that Buchanan will forfeit all equity awards, including a $2.5 million signing bonus.
The company also announced that CVS Caremark has partnered with Novo Nordisk to ease access to the latter's popular GLP-1 drug Wegovy.
Consumers’ expectations for the future hit a 13-year low.
According to GlobalData’s report “Pharma M&A Trends – Q1 2025,” oncology remains the leading therapeutic area in Q1 2025, with most of the deals targeting cancer-related assets.
Appier's AI solutions enabled L'Oréal to strategically identify and engage high-value customer segments.
This launch marks a milestone in Walmart’s strategy to convert over 150 stores nationwide in the coming years, reinforcing its commitment to retail modernization and community growth.
This tribute was particularly significant as Jim has been instrumental in constantly transforming and sustaining the NACDS Annual Meeting and other NACDS meetings and conferences as premier events that foster industry relationships and drive advancement.
Sampling efforts will be rolled out both digitally and on the ground in the New York Metro area.
Since launching in 2019, the program has supplied more than 6.5 million meals, supporting campus food pantries or local Feeding America partner food banks.
“Mars Tricks, Treats and Trends” report shows some Americans are already embracing the Halloween spirit.
The 2025 edition of Cosmoprof North America will feature a thoughtfully expanded show floor.
Events and programs throughout May will offer several ways to adopt, give back and save all month long.
This study compares the 50 states and the District in terms of 20 key metrics, ranging from arrest and overdose rates to opioid prescriptions and employee drug testing laws.
NASP opposes the legislation as passed by the Committee but commits to working with the bill sponsors, committee leadership and House leadership in an effort to address specialty pharmacy’s concerns.